scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1019036953 |
P356 | DOI | 10.1023/A:1007934832359 |
P932 | PMC publication ID | 3466752 |
P698 | PubMed publication ID | 9474806 |
P2093 | author name string | E Sato | |
S Furukawa | |||
M Totsuka | |||
A Ametani | |||
S Kaminogawa | |||
P2860 | cites work | Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand | Q67903498 |
Monoclonal antibodies as probes for monitoring the denaturation process of bovine beta-lactoglobulin | Q69102698 | ||
Location of sulfhydryl and disulfide groups in bovine .beta.-lactoglobulins and effects of urea | Q69238199 | ||
Capacity of intact proteins to bind to MHC class II molecules | Q69741058 | ||
Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides | Q70648993 | ||
Unfolding/refolding studies on bovine beta-lactoglobulin with monoclonal antibodies as probes. Does a renatured protein completely refold? | Q72102531 | ||
Peptide and protein antigens require distinct antigen-presenting cell subsets for the priming of CD4+ T cells | Q72191639 | ||
A single amino acid substitution in core residues of S-antigen prevents experimental autoimmune uveitis | Q72363621 | ||
Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses | Q73082028 | ||
Compilation and comparison of the sequence context around the AUG startcodons in Saccharomyces cerevisiae mRNAs | Q24628735 | ||
Transformation of intact yeast cells treated with alkali cations | Q24672708 | ||
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide | Q27731272 | ||
T cell receptor antagonist peptides induce positive selection | Q29618820 | ||
Tryptophan-19 of beta-lactoglobulin, the only residue completely conserved in the lipocalin superfamily, is not essential for binding retinol, but relevant to stabilizing bound retinol and maintaining its structure | Q30194187 | ||
Partial activation of CD8+ T cells by a self-derived peptide | Q30463698 | ||
Expression and secretion of bovine beta-lactoglobulin in Saccharomyces cerevisiae | Q30988444 | ||
Kinetic proofreading in T-cell receptor signal transduction | Q34285825 | ||
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. | Q34350288 | ||
Fine mapping of T-cell determinants of bovine beta-lactoglobulin | Q36304716 | ||
Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling | Q36361605 | ||
Th2 cell clonal anergy as a consequence of partial activation | Q36363894 | ||
Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production | Q36364188 | ||
Partial signaling by CD8+ T cells in response to antagonist ligands | Q36367003 | ||
Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing | Q36376999 | ||
A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens | Q36562710 | ||
Enhanced bacteriolytic activity of hen egg-white lysozyme due to conversion of Trp62 to other aromatic amino acid residues | Q38344490 | ||
T cell receptor antagonists and partial agonists | Q40438235 | ||
Ligands for the T-cell receptor: hard times for avidity models | Q40543526 | ||
In vitro growth of murine T cells. I. Production of factors necessary for T cell growth | Q40693538 | ||
The biochemistry and cell biology of antigen processing and presentation | Q40898211 | ||
Essential flexibility in the T-cell recognition of antigen | Q40973329 | ||
Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology | Q41039639 | ||
Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity | Q41440548 | ||
Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells | Q41461980 | ||
Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants | Q41462011 | ||
T cell recognition of fibrinogen. A determinant on the A alpha-chain does not require processing. | Q41912354 | ||
A small variance in the antigenicity but not function of recombinant β-lactoglobulin purified from the culture supernatant of transformed yeast cells | Q42326974 | ||
Evidence for a differential avidity model of T cell selection in the thymus | Q45155438 | ||
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor | Q45986774 | ||
A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists | Q46121537 | ||
Promethean viruses? | Q59036906 | ||
Antigen-specific interaction between T and B cells | Q59063745 | ||
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells | Q59078526 | ||
A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire | Q63535316 | ||
P433 | issue | 1-3 | |
P304 | page(s) | 115-126 | |
P577 | publication date | 1997-11-01 | |
P1433 | published in | Cytotechnology | Q15752151 |
P1476 | title | Antigen-specific inhibition of CD4(+) T-cell responses to β-lactoglobulin by its single amino acid-substituted mutant form through T-cell receptor antagonism | |
P478 | volume | 25 |
Q74582131 | Autocrine B-cell stimulation by interleukin-2 during a cognate interaction with T-cells |
Q33664142 | Immunological self/nonself discrimination: integration of self vs nonself during cognate T cell interactions with antigen-presenting cells. |
Q80002710 | Induction of T-cell activation or anergy determined by the combination of intensity and duration of T-cell receptor stimulation, and sequential induction in an individual cell |
Q52623629 | Introducing site-specific glycosylation using protein engineering techniques reduces the immunogenicity of β-lactoglobulin. |
Q36254735 | Murine T cell lines can change CD25 expression patterns as well as proliferation and cell death patterns in response to interleukin 2. |
Search more.